Anúncio
Anúncio
ACAD
Acadia Pharmaceuticals Inc.
26.30
USDPatrocinado
-0.41
-1.54%
02 de jan., 15:56 UTC -5
Encerrado
Pós-Mercado
26.54
+0.23
+0.89%
Relatórios de Lucros ACAD
Rácio de surpresa positiva
ACAD separação 26 de 40 últimas estimativas.
65%
Próximo Relatório
Data do Próximo Relatório
24 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$299.10M
/$0.14
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+7.35%
/-66.67%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+15.22%
/-800.00%
Acadia Pharmaceuticals Inc. earnings per share and revenue
On 05 de nov. de 2025, ACAD reported earnings of 0.42 USD per share (EPS) for Q3 25, beating the estimate of 0.15 USD, resulting in a 178.15% surprise. Revenue reached 278.63 milhão, compared to an expected 282.00 milhão, with a -1.19% difference. The market reacted with a -3.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analistas forecast an EPS of 0.14 USD, with revenue projected to reach 299.10 milhão USD, implying an diminuir of -66.67% EPS, and aumentar of 7.35% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Acadia Pharmaceuticals Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Acadia Pharmaceuticals Inc. reported EPS of $0.42, beating estimates by 178.15%, and revenue of $278.63M, -1.19% below expectations.
How did the market react to Acadia Pharmaceuticals Inc.'s Q3 2025 earnings?
The stock price moved down -3.05%, changed from $22.33 before the earnings release to $21.65 the day after.
When is Acadia Pharmaceuticals Inc. expected to report next?
The next earning report is scheduled for 24 de fev. de 2026.
What are the forecasts for Acadia Pharmaceuticals Inc.'s next earnings report?
Based on 22
analistas, Acadia Pharmaceuticals Inc. is expected to report EPS of $0.14 and revenue of $299.10M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio